0075-8003 : Taxotere 20 mg/ml Intravenous Injection, Solution, Concentrate
| NDC: | 0075-8003 |
| Labeler: | Sanofi-aventis U.S. LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Taxotere |
| Dosage Form: | Intravenous Injection, Solution, Concentrate |
| Application #: | NDA020449 |
| Rev. Date: |
NDC Package Codes:
- 0075-8003-01: 1 VIAL, GLASS IN 1 CARTON (0075‑8003‑01) > 1 ML IN 1 VIAL, GLASS
Active Ingredients:
- Docetaxel
Dosage Strength:
- 20 mg/mL
Pharmaceutical Classes:
- Microtubule Inhibition [PE]
- Microtubule Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 0075-8004 Taxotere 80 mg/4ml Intravenous Injection, Solution, Concentrate by Sanofi-aventis U.S. LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0075-7700Next: 0075-8004 >
Related Discussions:
How long does abdominal edema last post taxotere and what can be done to relieve it.
My mother was diagnosed with ovarian cancer a little over a year ago. She went through a debulking surgery and platinum ... 2 replies
My mother was diagnosed with ovarian cancer a little over a year ago. She went through a debulking surgery and platinum ... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.